MEDTR PEER ANALYSIS

Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi — metric-by-metric comparison with peers and the industry median

MEDTRMeditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi

🇹🇷 Turkey · IS · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

MEDTRIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	MEDTR	OM	NNOX	LUNG	MXCT	TELA	Ind. Median
P/E	597.66	—	—	—	—	—	27.09
P/B	1.08	0.79	0.66	1.40	0.82	-9.84●	2.51
EV/EBITDA	10.94	—	—	—	—	—	15.39
P/S	1.18	0.75	5.73	0.72	4.27	0.63●	2.62

Financial Health
Metric	MEDTR	OM	NNOX	LUNG	MXCT	TELA	Ind. Median
Current Ratio	3.58	6.29	3.64	4.91	12.04●	3.61	3.28
Debt/Equity	1.0%	91.0%	6.0%	123.0%	10.4%	-1,084.3%●	44.7%
NetDebt/EBITDA	-1.64●	0.96	0.74	0.11	-0.08	-0.52	0.82

Profitability
Metric	MEDTR	OM	NNOX	LUNG	MXCT	TELA	Ind. Median
Net Margin	0.2%●	-63.7%	-523.8%	-60.1%	-121.2%	-49.3%	-5.7%
ROE	0.2%●	-53.2%	-50.1%	-86.2%	-21.3%	—	-8.6%
ROA	0.2%●	-27.2%	-44.4%	-39.3%	-18.4%	-54.2%	-6.4%
EBITDA Margin	9.4%●	-48.6%	-336.6%	-54.5%	-107.3%	-40.2%	5.2%

Growth + Dividend
Metric	MEDTR	OM	NNOX	LUNG	MXCT	TELA	Ind. Median
Rev. Growth	6.5%	2.0%	25.7%●	1.2%	-14.3%	13.5%	7.4%
NI Growth	-62.9%	—	—	—	—	—	16.7%
Div. Yield	1.1%	—	—	—	—	—	1.1%
Payout	656.3%	—	—	—	—	—	39.0%

Valuation
Metric	MEDTR	ANGEN	ONCSM	Ind. Median
P/E	597.66	—	121.43●	27.09
P/B	1.08●	1.31	13.25	2.51
EV/EBITDA	10.94●	34.63	25.26	15.39
P/S	1.18●	2.93	7.60	2.62

Financial Health
Metric	MEDTR	ANGEN	ONCSM	Ind. Median
Current Ratio	3.58●	2.31	2.25	3.28
Debt/Equity	1.0%●	28.1%	35.0%	44.7%
NetDebt/EBITDA	-1.64●	4.71	0.42	0.82

Profitability
Metric	MEDTR	ANGEN	ONCSM	Ind. Median
Net Margin	0.2%	-45.0%	6.3%●	-5.7%
ROE	0.2%	-21.0%	12.9%●	-8.6%
ROA	0.2%	-15.7%	8.0%●	-6.4%
EBITDA Margin	9.4%	9.8%	30.6%●	5.2%

Growth + Dividend
Metric	MEDTR	ANGEN	ONCSM	Ind. Median
Rev. Growth	6.5%	11.7%	39.1%●	7.4%
NI Growth	-62.9%	—	—	16.7%
Div. Yield	1.1%●	0.0%	0.0%	1.1%
Payout	656.3%	0.0%	0.0%	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on MEDTR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.